Literature DB >> 2136324

Relationship between preoperative amiodarone treatment and complications observed during anaesthesia for valvular cardiac surgery.

D Chassard1, M George, M Guiraud, J J Lehot, O Bastien, C Hercule, J Villard, S Estanove.   

Abstract

Two groups of ASA physical status class III and IV patients undergoing cardiac surgery were reviewed in an attempt to obtain more conclusive data concerning dangerous interactions between amiodarone and anaesthesia. The amiodarone group (Group 1, ten patients, cumulative dose 10 g) was compared with a control group (nine patients, Group 2). Amiodarone (A) and desethylamiodarone (NA) concentrations in plasma and myocardium were measured and haemodynamic and antiarrhythmic effects were analysed. Throughout anaesthesia haemodynamic status was similar in both groups. No correlation was found between A/NA and cardiac index changes. No patients needed intraaortic blood pressure augmentation or developed low systemic vascular resistances. Pacemaker dependency was similar in both groups and there was no evidence of increased anaesthetic risk. An excellent antiarrhythmic effect was obtained during the postoperative period. We conclude that preoperative treatment with amiodarone is effective against postoperative arrhythmias.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2136324     DOI: 10.1007/BF03005479

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  11 in total

1.  Effects of amiodarone on cardiac and coronary hemodynamics and on myocardial metabolism in patients with coronary artery disease.

Authors:  P Côté; M G Bourassa; J Delaye; A Janin; R Froment; P David
Journal:  Circulation       Date:  1979-06       Impact factor: 29.690

2.  Postoperative arrhythmias after coronary artery and cardiac valvular surgery detected by long-term electrocardiographic monitoring.

Authors:  E L Michelson; J Morganroth; H MacVaugh
Journal:  Am Heart J       Date:  1979-04       Impact factor: 4.749

3.  Efficacy and safety of long-term amiodarone in treatment of cardiac arrhythmias: dosage experience.

Authors:  C I Haffajee; J C Love; J S Alpert; G K Asdourian; K C Sloan
Journal:  Am Heart J       Date:  1983-10       Impact factor: 4.749

4.  Amiodarone-induced complications during coronary artery surgery.

Authors:  J D Gallagher; R W Lieberman; J Meranze; S R Spielman; N Ellison
Journal:  Anesthesiology       Date:  1981-08       Impact factor: 7.892

5.  Clinical efficacy of amiodarone as an antiarrhythmic agent.

Authors:  M B Rosenbaum; P A Chiale; M S Halpern; G J Nau; J Przybylski; R J Levi; J O Lázzari; M V Elizari
Journal:  Am J Cardiol       Date:  1976-12       Impact factor: 2.778

6.  Relationships between amiodarone dosage, drug concentrations, and adverse side effects.

Authors:  J J Heger; E N Prystowsky; D P Zipes
Journal:  Am Heart J       Date:  1983-10       Impact factor: 4.749

7.  Cardiac actions in the dog of a new antagonist of adrenergic excitation which does not produce competitive blockade of adrenoceptors.

Authors:  R Charlier
Journal:  Br J Pharmacol       Date:  1970-08       Impact factor: 8.739

Review 8.  Amiodarone: historical development and pharmacologic profile.

Authors:  B N Singh
Journal:  Am Heart J       Date:  1983-10       Impact factor: 4.749

9.  Life-threatening postoperative pulmonary complications in patients with previous amiodarone pulmonary toxicity undergoing cardiothoracic operations.

Authors:  P C Nalos; R M Kass; E S Gang; M C Fishbein; W J Mandel; T Peter
Journal:  J Thorac Cardiovasc Surg       Date:  1987-06       Impact factor: 5.209

10.  Amiodarone and its desethyl metabolite: tissue distribution and morphologic changes during long-term therapy.

Authors:  P C Adams; D W Holt; G C Storey; A R Morley; J Callaghan; R W Campbell
Journal:  Circulation       Date:  1985-11       Impact factor: 29.690

View more
  2 in total

1.  Amiodarone and anaesthesia: concurrent therapy with ACE inhibitors--an additional cause for concern?

Authors:  J H Mackay; I A Walker; D W Bethune
Journal:  Can J Anaesth       Date:  1991-07       Impact factor: 5.063

Review 2.  Safety considerations in the use of drug combinations during general anaesthesia.

Authors:  E S Ransom; R A Mueller
Journal:  Drug Saf       Date:  1997-02       Impact factor: 5.606

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.